Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
45 participants
INTERVENTIONAL
2018-01-29
2018-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony (FOCUS-Right)
NCT06601322
Non Invasive Arrhythmia Detection in Hospital Settings
NCT00919087
Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device
NCT00833352
Non-Invasive 3D Mapping for Identifying Origin and Preferential Propagation of Ventricular Arrhythmias
NCT03831516
The SMART-LV Pilot Study
NCT05630170
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Single Arm
All patients will undergo standard of care ablation procedures. VIVO™ results will be compared to that of standard of care results, but will not be used in diagnosis or treatment.
VIVO™
Diagnose the area of a PVC or VT onset
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
VIVO™
Diagnose the area of a PVC or VT onset
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects who are scheduled for PVC/VT ablation procedure with structurally normal hearts and less than 10% scar.
* Subjects who have signed an IRB/EC approved Informed Consent Form and applicable subject privacy protection authorization per local law
* Subjects will be selected without regard to gender or age (unless precluded by local regulatory requirements)
Exclusion Criteria
* Subject whose MRI or CT scan does not comply with the requirements of this protocol
* Subjects who are contraindicated for an electrophysiology procedure and/or fluoroscopy:
* INR \> 3
* Active infection
* Pregnancy: Females of childbearing potential with a positive pregnancy test.
* Existing mechanical heart valve
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catheter Precision. Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Missiaen Huck
Role: STUDY_DIRECTOR
Catheter Precision. Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Iowa
Iowa City, Iowa, United States
Johns Hopkins Unveristy
Baltimore, Maryland, United States
Medical Unversity of South Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
94-9001-004
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.